"We are excited to be entering into this collaboration with Synfini to accelerate drug discovery around a publicly available high-value target,” said Helena Mancebo, CEO of Multispan. "By using ...

During the oral presentation “Cell Mimics As High Precision Controls for CGT Analytics and Potency Assays” Robyn Hall ... business generates asset-based fees, which are calculated as a ...

In the ever-evolving cell therapy landscape, the challenge of potency assay development remains critical. At the 4th Cell Therapy Potency Assay Summit, we will unite analytical development ...

label-free confocal imaging for live and kinetic investigations High throughput improves efficiency Reliable and proven technology Following the requirement for cell-based assay and phenotypic ...

Cellular immunogenicity and immunotoxicity assays help scientists design ... A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors. In ...

Boston, May 02, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, the demand for Cell-Based Assays: Technologies and Global Markets is estimated to increase from $35.3 billion ...

TruCytes Potency cell mimics offer a customizable, scalable, and efficient alternative to cell line target cells. This helps CAR-T developers accelerate assay validation and lot release ...

Join the meeting and leave equipped with industry insights that enable you to develop practical and reproducible assays, providing a deeper understanding of your cell therapy products for ...